IL88175A0 - Human immunoglobulins produced by recombinant dna techniques - Google Patents

Human immunoglobulins produced by recombinant dna techniques

Info

Publication number
IL88175A0
IL88175A0 IL88175A IL8817588A IL88175A0 IL 88175 A0 IL88175 A0 IL 88175A0 IL 88175 A IL88175 A IL 88175A IL 8817588 A IL8817588 A IL 8817588A IL 88175 A0 IL88175 A0 IL 88175A0
Authority
IL
Israel
Prior art keywords
recombinant dna
dna techniques
human immunoglobulins
immunoglobulins produced
produced
Prior art date
Application number
IL88175A
Other languages
English (en)
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of IL88175A0 publication Critical patent/IL88175A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL88175A 1987-10-28 1988-10-26 Human immunoglobulins produced by recombinant dna techniques IL88175A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11463287A 1987-10-28 1987-10-28
US25400488A 1988-09-16 1988-09-16

Publications (1)

Publication Number Publication Date
IL88175A0 true IL88175A0 (en) 1989-06-30

Family

ID=26812406

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88175A IL88175A0 (en) 1987-10-28 1988-10-26 Human immunoglobulins produced by recombinant dna techniques

Country Status (10)

Country Link
EP (1) EP0314161A1 (no)
JP (1) JPH02138989A (no)
AU (2) AU634151B2 (no)
DK (1) DK597288A (no)
FI (1) FI884924A (no)
IL (1) IL88175A0 (no)
MY (1) MY104344A (no)
NO (1) NO884795L (no)
NZ (1) NZ226694A (no)
PT (1) PT88874B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63267295A (ja) * 1986-12-03 1988-11-04 Sumitomo Chem Co Ltd ヒト抗体、抗体遺伝子及び対応する組換え体
US5610034A (en) * 1987-04-29 1997-03-11 Alko Group Ltd. Immunoglobulin production by trichoderma
CA2066720A1 (en) * 1989-09-19 1991-03-20 David M. Knight Method for improving human monoclonal antibody production
CA2045150A1 (en) * 1989-11-07 1991-05-08 Walt W. Shuford Oligomeric immunoglobulins
EP0539395A1 (en) * 1990-07-16 1993-05-05 Alko Group Ltd. IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA)
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
JP3502093B2 (ja) * 1991-07-15 2004-03-02 ザ・ウエルカム・ファウンデーション・リミテッド 抗体の製造
CA2078539C (en) * 1991-09-18 2005-08-02 Kenya Shitara Process for producing humanized chimera antibody
US5939532A (en) * 1993-09-07 1999-08-17 Kyowa Hakko Kogyo Co., Ltd Humanized antibodies to ganglioside GM2
AU669379B2 (en) * 1992-09-07 1996-06-06 Kyowa Hakko Kirin Co., Ltd. Humanized antibodies
US6042828A (en) 1992-09-07 2000-03-28 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
JP4799801B2 (ja) 2000-08-11 2011-10-26 協和発酵キリン株式会社 リン酸代謝、カルシウム代謝、石灰化及びビタミンｄ代謝を調節するポリペプチド並びにそれをコードするｄｎａ
EP2009027B1 (en) 2001-04-27 2014-05-21 Kyowa Hakko Kirin Co., Ltd. Anti-CD40 monoclonal antibody
CA2471656C (en) 2001-12-28 2012-07-31 Kirin Beer Kabushiki Kaisha Antibody against fibroblast growth factor-23
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
CA2872136C (en) 2002-07-18 2017-06-20 Merus B.V. Recombinant production of mixtures of antibodies
CA2527694C (en) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP1707627B1 (en) 2003-12-25 2012-11-14 Kyowa Hakko Kirin Co., Ltd. Antagonistic anti-CD40 antibody mutant
EP1737971B1 (en) 2004-01-20 2017-08-16 Merus N.V. Mixtures of binding proteins
CN101010427B (zh) 2004-09-06 2011-07-27 协和发酵麒麟株式会社 抗a33抗体
JP4294082B2 (ja) 2006-03-23 2009-07-08 協和発酵キリン株式会社 ヒトトロンボポエチン受容体に対するアゴニスト抗体
TWI390034B (zh) 2006-04-06 2013-03-21 Kyowa Hakko Kirin Co Ltd Novel anti-CD98 antibody
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7883705B2 (en) 2007-02-14 2011-02-08 Kyowa Hakko Kirin Co., Ltd. Anti FGF23 antibody and a pharmaceutical composition comprising the same
MX338067B (es) 2008-07-16 2016-04-01 Inst Research In Biomedicine Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos.
ES2743399T3 (es) 2012-04-20 2020-02-19 Merus Nv Métodos y medios para la producción de moléculas heterodiméricas similares a Ig
CN104736174B (zh) 2012-07-06 2019-06-14 根马布私人有限公司 具有三重突变的二聚体蛋白质
EP2711426B1 (en) * 2012-09-24 2015-04-08 Lonza Biologics plc Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
EP3470431A1 (en) 2012-09-27 2019-04-17 Merus N.V. Bispecific igg antibodies as t cell engagers
WO2015130172A1 (en) 2014-02-28 2015-09-03 Merus B.V. Antibodies that bind egfr and erbb3
US11279770B2 (en) 2014-02-28 2022-03-22 Merus N.V. Antibody that binds ErbB-2 and ErbB-3
DK3115376T3 (en) 2015-07-10 2018-11-26 Merus Nv HUMANT CD3 BINDING ANTIBODY
CN108602888B (zh) 2015-10-23 2022-10-04 美勒斯公司 抑制癌症生长的结合分子
AU2018246873B2 (en) 2017-03-31 2021-05-06 Merus N.V. ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment f cells that have an NRG1 fusion gene
SG11202001050PA (en) 2017-08-09 2020-03-30 Merus Nv Antibodies that bind egfr and cmet
TW201930351A (zh) 2017-10-06 2019-08-01 日商小野藥品工業股份有限公司 雙特異性抗體
TWI804572B (zh) 2018-02-09 2023-06-11 日商小野藥品工業股份有限公司 雙特異性抗體
TW202102544A (zh) 2019-04-04 2021-01-16 日商小野藥品工業股份有限公司 雙特異性抗體
WO2021006199A1 (ja) 2019-07-05 2021-01-14 小野薬品工業株式会社 Ｐｄ－１／ｃｄ３二重特異性タンパク質による血液がん治療
TW202118790A (zh) 2019-07-30 2021-05-16 日商小野藥品工業股份有限公司 雙特異性抗體
WO2021025140A1 (ja) 2019-08-08 2021-02-11 小野薬品工業株式会社 二重特異性タンパク質

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3689123T2 (de) * 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.

Also Published As

Publication number Publication date
EP0314161A1 (en) 1989-05-03
AU2436388A (en) 1989-06-01
DK597288D0 (da) 1988-10-27
PT88874A (pt) 1989-07-31
DK597288A (da) 1989-04-29
NO884795D0 (no) 1988-10-27
AU634151B2 (en) 1993-02-18
AU2608292A (en) 1992-12-17
NO884795L (no) 1989-04-28
PT88874B (pt) 1994-01-31
NZ226694A (en) 1994-04-27
FI884924A (fi) 1989-04-29
MY104344A (en) 1994-03-31
FI884924A0 (fi) 1988-10-25
JPH02138989A (ja) 1990-05-28

Similar Documents

Publication Publication Date Title
IL88175A0 (en) Human immunoglobulins produced by recombinant dna techniques
ZA872705B (en) Human g-csf protein expression
AU1167483A (en) Dna sequences for producing human immune interferon-like polypeptides
PH25327A (en) Binfunctional proteins
GB8724412D0 (en) Protein
GB8823068D0 (en) Recombinant dna
EP0279459A3 (en) Anticoagulant polypeptide
GB2068970B (en) Recombinant dna technique for the preparation of a protein resembling human interferon
GB8729251D0 (en) Human cytomegalovirus protein
GB8701160D0 (en) Hybrid proteins
IL61994A0 (en) Recombinatn dna technique for the preparation of a protein resembling human interferon
ZA887305B (en) Human immunoglobulins produced by recombinant dna techniques
IE883256L (en) Human immunoglobulins by recombinant dna techniques
PT86162A (en) Recombinant protein expression
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
GB8725462D0 (en) Protein
GB8713559D0 (en) Structural proteins
GB8725463D0 (en) Protein
GB8726581D0 (en) Dna sequence
JPS6410000A (en) Human splenine
GB8623925D0 (en) Recombinant dna methods
GB8631071D0 (en) Recombinant dna
IE873131L (en) Recombinant protein expression.
IE862835L (en) Protein modification
GB8609162D0 (en) Protein